Efficacy of silodosin in benign prostatic hyperplasia with overactive bladder.

Trial Profile

Efficacy of silodosin in benign prostatic hyperplasia with overactive bladder.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs Silodosin (Primary)
  • Indications Benign prostatic hyperplasia; Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2016 Status changed from recruiting to completed as per results published in the International Journal of Urology
    • 04 Sep 2012 Actual initiation date changed from Feb 2011 to Jan 2008, as reported by University Hospital Medical Information Network - Japan.
    • 04 Sep 2012 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top